Live Breaking News & Updates on Revance Therapeutics

Stay updated with breaking news from Revance therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Revance Therapeutics (NASDAQ:RVNC) Price Target Lowered to $8.00 at The Goldman Sachs Group

Revance Therapeutics (NASDAQ:RVNC) Price Target Lowered to $8.00 at The Goldman Sachs Group
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states , Piper-sandler , Dustins-sjuts , Tobin-schilke , Revance-therapeutics-company-profile , Barclays , Asset-management-inc , Needham-company , Securities-exchange-commission , Goldman-sachs-group , Invesco-ltd , Revance-therapeutics-inc

Contineum Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights

-Contineum is focused on leading the Neuroscience, Inflammation and Immunology field-

-Successful completion of Initial Public Offering with strong syndicate of existing and new investors-

. ....

San-diego , California , United-states , Carmine-stengone , Third-development , Contineum-therapeutics-inc , Arcellx-inc , Davidson-college , Johnson , Nasdaq , Development-expenses , Drug-administration

Needham & Company LLC Cuts Revance Therapeutics (NASDAQ:RVNC) Price Target to $12.00

Needham & Company LLC Cuts Revance Therapeutics (NASDAQ:RVNC) Price Target to $12.00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Switzerland , United-states , Swiss , Tobin-schilke , Piper-sandler , Dustins-sjuts , Essex-investment-management-co , Swiss-national-bank , Revance-therapeutics-inc , Northrock-partners , Goldman-sachs-group , Securities-exchange-commission

Mizuho Lowers Revance Therapeutics (NASDAQ:RVNC) Price Target to $8.00

Mizuho Lowers Revance Therapeutics (NASDAQ:RVNC) Price Target to $8.00
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United-states , Switzerland , Swiss , Piper-sandler , Tobin-schilke , Securities-exchange-commission , Revance-therapeutics-company-profile , Blair-william-co , Needham-company , Goldman-sachs-group , Northrock-partners , Essex-investment-management-co

Revance Therapeutics, Inc. (NASDAQ:RVNC) Q1 2024 Earnings Call Transcript

Revance Therapeutics, Inc. (NASDAQ:RVNC) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

Mark-foley , Chris-shibutani , Annabel-samimy , Tobin-schilke , Seamus-fernandez , Stacy-ku , Toby-schilke , Nasdaq , Revance-therapeutics-inc , Goldman-sachs , Revance-therapeutics , Call-transcript-may